Simultaneously, however, PRDX1 can protect breast cancer cells from the effects of certain forms of treatment [23,24], including prooxidant compounds [13], and therefore can be regarded an attractive target for anticancer therapies in mammary malignancies. Here, PRDX1 is linked to breast carcinoma.